BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31665262)

  • 1. mCSM-AB2: guiding rational antibody design using graph-based signatures.
    Myung Y; Rodrigues CHM; Ascher DB; Pires DEV
    Bioinformatics; 2020 Mar; 36(5):1453-1459. PubMed ID: 31665262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mmCSM-AB: guiding rational antibody engineering through multiple point mutations.
    Myung Y; Pires DEV; Ascher DB
    Nucleic Acids Res; 2020 Jul; 48(W1):W125-W131. PubMed ID: 32432715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSM-AB: graph-based antibody-antigen binding affinity prediction and docking scoring function.
    Myung Y; Pires DEV; Ascher DB
    Bioinformatics; 2022 Jan; 38(4):1141-1143. PubMed ID: 34734992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures.
    Pires DE; Ascher DB
    Nucleic Acids Res; 2016 Jul; 44(W1):W469-73. PubMed ID: 27216816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Graph-Based Signatures to Guide Rational Antibody Engineering.
    Ascher DB; Kaminskas LM; Myung Y; Pires DEV
    Methods Mol Biol; 2023; 2552():375-397. PubMed ID: 36346604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mCSM-membrane: predicting the effects of mutations on transmembrane proteins.
    Pires DEV; Rodrigues CHM; Ascher DB
    Nucleic Acids Res; 2020 Jul; 48(W1):W147-W153. PubMed ID: 32469063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mCSM-PPI2: predicting the effects of mutations on protein-protein interactions.
    Rodrigues CHM; Myung Y; Pires DEV; Ascher DB
    Nucleic Acids Res; 2019 Jul; 47(W1):W338-W344. PubMed ID: 31114883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mCSM-NA: predicting the effects of mutations on protein-nucleic acids interactions.
    Pires DEV; Ascher DB
    Nucleic Acids Res; 2017 Jul; 45(W1):W241-W246. PubMed ID: 28383703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance.
    Pires DE; Blundell TL; Ascher DB
    Sci Rep; 2016 Jul; 6():29575. PubMed ID: 27384129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mmCSM-PPI: predicting the effects of multiple point mutations on protein-protein interactions.
    Rodrigues CHM; Pires DEV; Ascher DB
    Nucleic Acids Res; 2021 Jul; 49(W1):W417-W424. PubMed ID: 33893812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pdCSM-GPCR: predicting potent GPCR ligands with graph-based signatures.
    Velloso JPL; Ascher DB; Pires DEV
    Bioinform Adv; 2021; 1(1):vbab031. PubMed ID: 34901870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mmCSM-NA: accurately predicting effects of single and multiple mutations on protein-nucleic acid binding affinity.
    Nguyen TB; Myung Y; de Sá AGC; Pires DEV; Ascher DB
    NAR Genom Bioinform; 2021 Dec; 3(4):lqab109. PubMed ID: 34805992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSM-carbohydrate: protein-carbohydrate binding affinity prediction and docking scoring function.
    Nguyen TB; Pires DEV; Ascher DB
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34882232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinact: a computational approach for predicting activating missense mutations in protein kinases.
    Rodrigues CH; Ascher DB; Pires DE
    Nucleic Acids Res; 2018 Jul; 46(W1):W127-W132. PubMed ID: 29788456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EasyVS: a user-friendly web-based tool for molecule library selection and structure-based virtual screening.
    Pires DEV; Veloso WNP; Myung Y; Rodrigues CHM; Silk M; Rezende PM; Silva F; Xavier JS; Velloso JPL; da Silveira CH; Ascher DB
    Bioinformatics; 2020 Aug; 36(14):4200-4202. PubMed ID: 32399551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mCSM: predicting the effects of mutations in proteins using graph-based signatures.
    Pires DE; Ascher DB; Blundell TL
    Bioinformatics; 2014 Feb; 30(3):335-42. PubMed ID: 24281696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pdCSM-PPI: Using Graph-Based Signatures to Identify Protein-Protein Interaction Inhibitors.
    Rodrigues CHM; Pires DEV; Ascher DB
    J Chem Inf Model; 2021 Nov; 61(11):5438-5445. PubMed ID: 34719929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability.
    Rodrigues CH; Pires DE; Ascher DB
    Nucleic Acids Res; 2018 Jul; 46(W1):W350-W355. PubMed ID: 29718330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations.
    Rodrigues CHM; Pires DEV; Ascher DB
    Protein Sci; 2021 Jan; 30(1):60-69. PubMed ID: 32881105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDMut: predicting effects of mutations on protein stability using deep learning.
    Zhou Y; Pan Q; Pires DEV; Rodrigues CHM; Ascher DB
    Nucleic Acids Res; 2023 Jul; 51(W1):W122-W128. PubMed ID: 37283042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.